Isis Pharmaceuticals to Present at the 2014 RBC Capital Markets Global Healthcare Conference
[PR Newswire] – CARLSBAD, Calif., Feb. 19, 2014 /PRNewswire/ — Isis Pharmaceuticals, Inc. (ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the 2014 RBC Capital Markets Global Healthcare Con more
View todays social media effects on ISIS
View the latest stocks trending across Twitter. Click to view dashboard